CompletedPhase 1NCT01981525
A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome
Studying Li-Fraumeni syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Christina M Annunziata, M.D.National Cancer Institute (NCI)
- Intervention
- Metformin(drug)
- Enrollment
- 26 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2020
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01981525 on ClinicalTrials.govOther trials for Li-Fraumeni syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06712095Video Capsule Examination in Patients With Lynch SyndromeRoyal Marsden NHS Foundation Trust
- RECRUITINGPHASE2NCT06088030Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric CancerYang Li
- RECRUITINGNCT05126810Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic CounselingM.D. Anderson Cancer Center
- RECRUITINGNCT04541654Li-Fraumeni & TP53 (LiFT UP): Understanding and ProgressDana-Farber Cancer Institute
- RECRUITINGNCT04982744Registry of Li Fraumeni and Li Fraumeni Like SyndromesIstituto Ortopedico Rizzoli
- RECRUITINGNCT04367246Li-Fraumeni Syndrome/TP53 BiobankAbramson Cancer Center at Penn Medicine
- ENROLLING BY INVITATIONNANCT03176836Li-Fraumeni Syndrome Imaging StudyThe Hospital for Sick Children
- ACTIVE NOT RECRUITINGNANCT02950987Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition SyndromesDana-Farber Cancer Institute